These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32973127)

  • 21. Tris (2-chloroethyl) phosphate induces senescence-like phenotype of hepatocytes via the p21
    Zhang W; Zhang Y; Hou J; Xu T; Yin W; Xiong W; Lu W; Zheng H; Chen J; Yuan J
    Environ Toxicol Pharmacol; 2017 Dec; 56():68-75. PubMed ID: 28886428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.
    Mackenzie Ross AD; Cook MG; Chong H; Hossain M; Pandha HS; Bennett DC
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):226-35. PubMed ID: 23253087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds.
    Cairney CJ; Godwin LS; Bilsland AE; Burns S; Stevenson KH; McGarry L; Revie J; Moore JD; Wiggins CM; Collinson RS; Mudd C; Tsonou E; Sadaie M; Bennett DC; Narita M; Torrance CJ; Keith WN
    PLoS Genet; 2017 Aug; 13(8):e1006942. PubMed ID: 28806777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53: The pivot between cell cycle arrest and senescence.
    Santoro R; Blandino G
    Cell Cycle; 2010 Nov; 9(21):4262-3. PubMed ID: 21057199
    [No Abstract]   [Full Text] [Related]  

  • 25. Arecoline-induced phosphorylated p53 and p21(WAF1) protein expression is dependent on ATM/ATR and phosphatidylinositol-3-kinase in clone-9 cells.
    Chou WW; Guh JY; Tsai JF; Hwang CC; Chiou SJ; Chuang LY
    J Cell Biochem; 2009 Jun; 107(3):408-17. PubMed ID: 19343784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest.
    Beckerman R; Yoh K; Mattia-Sansobrino M; Zupnick A; Laptenko O; Karni-Schmidt O; Ahn J; Byeon IJ; Keezer S; Prives C
    Cell Cycle; 2016 Jun; 15(11):1425-38. PubMed ID: 27210019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting enhancer of zeste homolog 2 promotes cellular senescence in gastric cancer cells SGC-7901 by activation of p21 and p16.
    Bai J; Chen J; Ma M; Cai M; Xu F; Wang G; Tao K; Shuai X
    DNA Cell Biol; 2014 Jun; 33(6):337-44. PubMed ID: 24588771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway.
    Zhang F; Li M; Wu X; Hu Y; Cao Y; Wang X; Xiang S; Li H; Jiang L; Tan Z; Lu W; Weng H; Shu Y; Gong W; Wang X; Zhang Y; Shi W; Dong P; Gu J; Liu Y
    Drug Des Devel Ther; 2015; 9():3969-87. PubMed ID: 26309394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.
    Kortlever RM; Higgins PJ; Bernards R
    Nat Cell Biol; 2006 Aug; 8(8):877-84. PubMed ID: 16862142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of senescence by adenosine suppressing the growth of lung cancer cells.
    Yang D; Song J; Wu L; Ma Y; Song C; Dovat S; Nishizaki T; Liu J
    Biochem Biophys Res Commun; 2013 Oct; 440(1):62-7. PubMed ID: 24051088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA-Binding Protein FXR1 Regulates p21 and TERC RNA to Bypass p53-Mediated Cellular Senescence in OSCC.
    Majumder M; House R; Palanisamy N; Qie S; Day TA; Neskey D; Diehl JA; Palanisamy V
    PLoS Genet; 2016 Sep; 12(9):e1006306. PubMed ID: 27606879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenite induces premature senescence via p53/p21 pathway as a result of DNA damage in human malignant glioblastoma cells.
    Ninomiya Y; Cui X; Yasuda T; Wang B; Yu D; Sekine-Suzuki E; Nenoi M
    BMB Rep; 2014 Oct; 47(10):575-80. PubMed ID: 24499675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Egg antigen p40 of Schistosoma japonicum promotes senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway.
    Chen J; Xu T; Zhu D; Wang J; Huang C; Lyu L; Hu B; Sun W; Duan Y
    Cell Death Dis; 2016 Jul; 7(7):e2315. PubMed ID: 27468691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RXRα provokes tumor suppression through p53/p21/p16 and PI3K-AKT signaling pathways during stem cell differentiation and in cancer cells.
    Zhang R; Li H; Zhang S; Zhang Y; Wang N; Zhou H; He H; Hu G; Zhang TC; Ma W
    Cell Death Dis; 2018 May; 9(5):532. PubMed ID: 29748541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial nucleoid remodeling and biogenesis are regulated by the p53-p21
    Lee YY; Choi YS; Kim DW; Cheong JY; Song KY; Ryu MS; Lim IK
    Aging (Albany NY); 2020 Apr; 12(8):6700-6732. PubMed ID: 32330121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
    Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
    Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways.
    Tu Y; Wu W; Wu T; Cao Z; Wilkins R; Toh BH; Cooper ME; Chai Z
    J Biol Chem; 2007 Apr; 282(16):11722-31. PubMed ID: 17317670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
    Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
    Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p21 and p27 a shared senescence history.
    Flores JM; Martín-Caballero J; García-Fernández RA
    Cell Cycle; 2014; 13(11):1655-6. PubMed ID: 24809983
    [No Abstract]   [Full Text] [Related]  

  • 40. p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
    Gu Z; Jiang J; Tan W; Xia Y; Cao H; Meng Y; Da Z; Liu H; Cheng C
    Clin Dev Immunol; 2013; 2013():134243. PubMed ID: 24151513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.